Stock Rich List
#3732 on the rich list of 14,452 insiders

Morana Jovan-Embiricos

10% owner at Cullinan Therapeutics; Director at Kalaris Therapeutics. Based in Waltham, Massachusetts.

$30.5M
in disclosed stock, +$184K (+0.61%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3732nd of 14,452
Companies held
2
Largest holding
CGEM, 97.3% of total
Latest SEC filing
Jun 6, 2024
Listed but not counted
$11.8M

What the $30.5M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Cullinan Therapeutics CGEM
Common Stock
Directly1,255,963$9.07$11.4M37.3%Form 4, Aug 4, 2022
Cullinan Therapeutics CGEM
Common Stock
Through Globeways Holdings Ltd.
Reported jointly by 2 insiders; split evenly
568,263$9.07$5.2M16.9%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 Bioscience I 2017 Ltd.537,392$9.07$4.9M16.0%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2-TPO Investments, LLC
Reported jointly by 2 insiders; split evenly
311,088$9.07$2.8M9.2%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through Morana Jovan-Embiricos207,803$9.07$1.9M6.2%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 MG Ltd.
Reported jointly by 2 insiders; split evenly
162,667$9.07$1.5M4.8%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 MC, LLC
Reported jointly by 2 insiders; split evenly
107,399$9.07$974K3.2%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 Bio TD, LLC71,599$9.07$649K2.1%Form 4, Aug 2, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 GC, LLC
Reported jointly by 2 insiders; split evenly
52,381$9.07$475K1.6%Form 4, Aug 2, 2022
Kalaris Therapeutics KLRS
Common Stock
Through F2 Capital I 2020182,342
split-adjusted
$1.35$246K0.8%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
Shares held by ElevateBio LLC
Reported jointly by 4 insiders; split evenly
181,247
split-adjusted
$1.35$245K0.8%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
F2 MG Ltd.89,560
split-adjusted
$1.35$121K0.4%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
Shares held by F2 MC, LLC88,634
split-adjusted
$1.35$120K0.4%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
F2 Bioscience AV 2022 LLC37,725
split-adjusted
$1.35$51K0.2%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
Shares held by F2 TPO Investments, LLC29,047
split-adjusted
$1.35$39K0.1%Form 4, Jun 6, 2024
Kalaris Therapeutics KLRS
Common Stock
Directly4,356
split-adjusted
$1.35$6K0.0%Form 4, Jun 6, 2024

Share counts are the amounts Morana Jovan-Embiricos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Morana Jovan-Embiricos's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Cullinan Therapeutics CGEM
Common Stock
Through F2 Vision SCS
Counted on the profile of the insider who holds these shares directly
1,305,873$9.07$11.8M—Form 4, Jun 24, 2022

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3729Jonathan G. Weiss
Sr. Executive Vice President, Wells Fargo &. New York, NY
$30.6M−$118K (−0.38%)
3730David N. Watson
CEO - Comcast Cable, Comcast. Tempe, AZ
$30.5M−$550K (−1.77%)
3731Omer Shai
CMO, Wix.com
$30.5M−$2.2M (−6.75%)
3732Morana Jovan-Embiricos
10% owner, Cullinan Therapeutics. Waltham, MA
$30.5M+$184K (+0.61%)
3733Margaret Anne McAllister
10% owner, Hamilton Lane. Conshohocken, PA
$30.5M−$790K (−2.52%)
3734Gordon Crawford
Director, Lionsgate Studios. Santa Monica, CA
$30.5M−$815K (−2.60%)
3735Robert A. Iger
Chief Executive Officer, The Walt Disney. Burbank, CA
$30.5M−$535K (−1.72%)

Other Cullinan Therapeutics insiders

All CGEM insiders

Questions

How much stock does Morana Jovan-Embiricos own?

Morana Jovan-Embiricos holds $30,527,632 in listed stock based on SEC filings and current prices, mostly Cullinan Therapeutics (CGEM). That ranks 3732nd on the Stock Rich List.

Is this Morana Jovan-Embiricos's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with Vision Scs F2.